Introduction Efficient preventive management of acute exacerbation of chronic obstructive pulmonary disease (COPD) is ...

Physical activity, particularly walking, is a common recommendation for people with chronic obstructive pulmonary disease (COPD). However, carrying out this activity in polluted areas may increase ...

Tick bite-related ER visits are at their highest seasonal levels since 2017 across most U.S. regions, raising concerns about increased Lyme disease and other tick-borne illnesses. That’s according to ...

Researchers found unusually high hantavirus levels in rodents in the Pacific Northwest, suggesting greater exposure risk in the surrounding agricultural communities. The area with the biggest ...

Researchers found unusually high hantavirus levels in rodents in the Pacific Northwest, suggesting greater exposure risk in the surrounding agricultural communities. The area with the biggest ...

The Centers for Disease Control and Prevention (CDC) has activated its 24/7 emergency center and classified hantavirus at the lowest activation level, according to a report Thursday evening. The CDC’s ...

It took just 48 hours for Ben Lopman’s 18-month-old son to go from being an energetic toddler to totally listless. Limited time: Save 25% on NBC News subscription Get exclusive reporting, live Q&As ...

WILMINGTON, Del.--(BUSINESS WIRE)--Positive high-level results from the Phase III OBERON and TITANIA trials in patients with chronic obstructive pulmonary disease (COPD) showed that tozorakimab ...

First-ever IL-33-targeting biologic to demonstrate statistically significant and highly clinically meaningful reductions in COPD exacerbations in two replicate Phase III clinical trials WILMINGTON, ...

First-ever IL-33-targeting biologic to demonstrate statistically significant and highly clinically meaningful reductions in COPD exacerbations in two replicate Phase III clinical trials Positive ...

Positive high-level results from the Phase III OBERON and TITANIA trials in patients with chronic obstructive pulmonary disease (COPD) showed that tozorakimab reduced the annualized rate of ...